These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14522091)

  • 1. High frequency of HLA-B44 allelic losses in human solid tumors.
    Cabrera T; Maleno I; Lopez-Nevot MA; Redondo M; Fernandez MA; Collado A; Garrido F
    Hum Immunol; 2003 Oct; 64(10):941-50. PubMed ID: 14522091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the chaperone tapasin in HLA-B44 allelic losses in colorectal tumors.
    Cabrera CM; López-Nevot MA; Jiménez P; Garrido F
    Int J Cancer; 2005 Feb; 113(4):611-8. PubMed ID: 15455354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of altered HLA class I phenotypes in laryngeal carcinomas.
    Cabrera T; Salinero J; Fernandez MA; Garrido A; Esquivias J; Garrido F
    Hum Immunol; 2000 May; 61(5):499-506. PubMed ID: 10773352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-A33 and -B44 and susceptibility to postherpetic neuralgia (PHN).
    Ozawa A; Sasao Y; Iwashita K; Miyahara M; Sugai J; Iizuka M; Kawakubo Y; Ohkido M; Naruse T; Anzai T; Takashige N; Ando A; Inoko H
    Tissue Antigens; 1999 Mar; 53(3):263-8. PubMed ID: 10203019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas.
    Cabrera T; Collado A; Fernandez MA; Ferron A; Sancho J; Ruiz-Cabello F; Garrido F
    Tissue Antigens; 1998 Aug; 52(2):114-23. PubMed ID: 9756399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.
    Grandis JR; Falkner DM; Melhem MF; Gooding WE; Drenning SD; Morel PA
    Clin Cancer Res; 2000 Jul; 6(7):2794-802. PubMed ID: 10914726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA class I antigen and HLA-A, -B, and -C haplotype frequencies in Uruguayans.
    Alvarez I; Bengochea M; Toledo R; Carretto E; Hidalgo PC
    Hum Biol; 2006 Aug; 78(4):513-25. PubMed ID: 17278625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new HLA-B44 allele (B*44020102S) with a splicing mutation leading to a complete deletion of exon 5.
    Dubois V; Tiercy JM; Labonne MP; Dormoy A; Gebuhrer L
    Tissue Antigens; 2004 Feb; 63(2):173-80. PubMed ID: 14705988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
    Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ
    Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines.
    Koopman LA; Mulder A; Corver WE; Anholts JD; Giphart MJ; Claas FH; Fleuren GJ
    Tissue Antigens; 1998 Jun; 51(6):623-36. PubMed ID: 9694355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
    Maleno I; López-Nevot MA; Cabrera T; Salinero J; Garrido F
    Cancer Immunol Immunother; 2002 Sep; 51(7):389-96. PubMed ID: 12192539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of HLA-B*44 alleles encoded on extended HLA haplotypes by direct automated sequencing.
    Petersdorf EW; Setoda T; Smith AG; Hansen JA
    Tissue Antigens; 1994 Oct; 44(4):211-6. PubMed ID: 7871521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell lines.
    Giacomini P; Giorda E; Fraioli R; Nicotra MR; Vitale N; Setini A; Delfino L; Morabito A; Benevolo M; Venturo I; Mottolese M; Ferrara GB; Natali PG
    Cancer Res; 1999 Jun; 59(11):2657-67. PubMed ID: 10363989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity at 6p21 and HLA class I expression in esophageal squamous cell carcinomas in China.
    Zhao X; Sun Q; Tian H; Cong B; Jiang X; Peng C
    Asian Pac J Cancer Prev; 2011; 12(10):2741-5. PubMed ID: 22320985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.
    Garrido MA; Rodriguez T; Zinchenko S; Maleno I; Ruiz-Cabello F; Concha Á; Olea N; Garrido F; Aptsiauri N
    Immunogenetics; 2018 Nov; 70(10):647-659. PubMed ID: 30145665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common
    Lim WC; Marques Da Costa ME; Godefroy K; Jacquet E; Gragert L; Rondof W; Marchais A; Nhiri N; Dalfovo D; Viard M; Labaied N; Khan AM; Dessen P; Romanel A; Pasqualini C; Schleiermacher G; Carrington M; Zitvogel L; Scoazec JY; Geoerger B; Salmon J
    Front Immunol; 2023; 14():1265469. PubMed ID: 38318504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of two major HLA-B44 subtypes and a novel B44 sequence (B*4404). Oligotyping and solid phase sequencing of polymerase chain reaction products.
    Yao Z; Keller E; Scholz S; McNicholas A; Volgger A; Albert ED
    Hum Immunol; 1995 Jan; 42(1):54-60. PubMed ID: 7751160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of altered HLA class I phenotypes in invasive breast carcinomas.
    Cabrera T; Angustias Fernandez M; Sierra A; Garrido A; Herruzo A; Escobedo A; Fabra A; Garrido F
    Hum Immunol; 1996 Oct; 50(2):127-34. PubMed ID: 8891736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-B44 subtypes and the chance of finding HLA compatible donor/recipient pairs for bone marrow transplantation: a haplotype study of 303 Italian families.
    Mattiuz PL; Di Paolo E; Fossombroni V; Menicucci A; Pradella F; Porfirio B; Rombolà G
    Tissue Antigens; 1997 Dec; 50(6):602-9. PubMed ID: 9458113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer.
    Koopman LA; Corver WE; van der Slik AR; Giphart MJ; Fleuren GJ
    J Exp Med; 2000 Mar; 191(6):961-76. PubMed ID: 10727458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.